A1C 5.7 to 6.4: Your GLP-1 Decision Framework
An A1C between 5.7% and 6.4% puts you in prediabetes, and the right move depends on where in that band you sit plus your other risk factors.
The 6-Month Maintenance Checkpoint: Audit Your Systems
Six months after reaching your goal weight is exactly when you should sit down and audit every system that got you there.
503A Peptide Pharmacies Explained: Why Sourcing Matters
Introduction A 503A pharmacy is a state-licensed compounding pharmacy that makes a medication for one specific patient based on a prescription, following USP quality…
The 5-Year View: Long-Term GLP-1 Users Tell the Truth
Five years into GLP-1 treatment, the people doing well share one belief: this is chronic disease management, not a diet with an end date.
5-Amino-1MQ vs MOTS-c: NNMT vs Mitochondrial Signaling
Introduction 5-Amino-1MQ and MOTS-c both get pitched for metabolism and body composition, but they work through different mechanisms, and that is the substance of…
Stacking 5-Amino-1MQ with GLP-1: What to Know Before Combining
There is no published evidence on stacking 5-Amino-1MQ with a GLP-1 medication, so any confident protocol is invented.
5-Amino-1MQ Side Effects: Complete Safety Profile and What to Watch
Introduction 5-Amino-1MQ is often grouped with peptides in wellness discussions, but it’s actually a small molecule, not a peptide, and it’s taken orally rather…
5-Amino-1MQ Research Review: What the Evidence Actually Shows
The honest summary of 5-Amino-1MQ research is that it has a clean, well-supported preclinical story and zero published human evidence.
How 5-Amino-1MQ Works: Mechanism of Action Explained Simply
5-Amino-1MQ works by blocking an enzyme called NNMT in fat cells, which raises NAD+ and shifts fat-cell metabolism away from storage.